Exploratory Prognostic Biomarkers of Complement-Mediated Thrombotic Microangiopathy (CM-TMA) in Adults with Atypical Hemolytic Uremic Syndrome (aHUS): Analysis of a Phase III Study of Ravulizumab
Cammett, Tobin J., Garlo, Katherine, Millman, Ellen E., Rice, Kara, Toste, Catherine M., Faas, Susan J.
Published in Molecular diagnosis & therapy (01.01.2023)
Published in Molecular diagnosis & therapy (01.01.2023)
Get full text
Journal Article
Correction to: Exploratory Prognostic Biomarkers of Complement-Mediated Thrombotic Microangiopathy (CM-TMA) in Adults with Atypical Hemolytic Uremic Syndrome (aHUS): Analysis of a Phase III Study of Ravulizumab
Cammett, Tobin J, Garlo, Katherine, Millman, Ellen E, Rice, Kara, Toste, Catherine M, Faas, Susan J.
Published in Molecular diagnosis & therapy (01.03.2023)
Published in Molecular diagnosis & therapy (01.03.2023)
Get full text
Journal Article